Effectiveness of Pcsk9 Inhibitor Treatment in Very-high Cardiovascular Risk Patients

Anna Gavrilova; Maria Lapsovs; Zanda E. Markova; Kārlis Trušinskis; Inga Urtane

Effectiveness of Pcsk9 Inhibitor Treatment in Very-high Cardiovascular Risk Patients

Anna Gavrilova
, Maria Lapsovs
, Zanda E. Markova
, Kārlis Trušinskis
, Inga Urtane

Department of Clinical and Personalized Medicine

Research output: Contribution to journal › Meeting abstract › peer-review

Original language	English
Pages (from-to)	558-558
Number of pages	1
Journal	International Journal of Clinical Pharmacy
Volume	47
Issue number	2
Publication status	Published - Apr 2025

Cite this

@article{c014cdc8487b4ee0bdef36ee31793307,

title = "Effectiveness of Pcsk9 Inhibitor Treatment in Very-high Cardiovascular Risk Patients",

author = "Anna Gavrilova and Maria Lapsovs and Markova, \{Zanda E.\} and Kārlis Tru{\v s}inskis and Inga Urtane",

year = "2025",

month = apr,

language = "English",

volume = "47",

pages = "558--558",

journal = "International Journal of Clinical Pharmacy",

issn = "2210-7703",

publisher = "Springer Science and Business Media Deutschland GmbH",

number = "2",

}

TY - JOUR

T1 - Effectiveness of Pcsk9 Inhibitor Treatment in Very-high Cardiovascular Risk Patients

AU - Gavrilova, Anna

AU - Lapsovs, Maria

AU - Markova, Zanda E.

AU - Trušinskis, Kārlis

AU - Urtane, Inga

PY - 2025/4

Y1 - 2025/4

UR - https://link.springer.com/article/10.1007/s11096-025-01891-6

UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=lub001&SrcAuth=WosAPI&KeyUT=WOS:001630229700170&DestLinkType=FullRecord&DestApp=WOS_CPL

M3 - Meeting abstract

SN - 2210-7703

VL - 47

SP - 558

EP - 558

JO - International Journal of Clinical Pharmacy

JF - International Journal of Clinical Pharmacy

IS - 2

ER -

Effectiveness of Pcsk9 Inhibitor Treatment in Very-high Cardiovascular Risk Patients

Other files and links

Cite this